(Q79901873)
Statements
CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin (English)
Lujia Dong
Tong Wu
Mei-Jie Zhang
Zhi-Yong Gao
1 December 2007